At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
QBSAfe Toolkitother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
In Brief
A clinical study evaluating QBSAfe Toolkit for Diabetes and Diabetes Mellitus. Completed, enrolled 91 participants across 3 sites.
Detailed Summary
The purpose of this study is to co-develop a toolkit (known as the QBSAfe toolkit) with patients, family caregivers, and clinicians that focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety for patients with diabetes mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Diabetes Mellitus
CountriesUnited States
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartApr 2020
First PostedAug 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedAug 17, 2020
Enrollment StartApr 28, 2020
Primary CompletionSep 22, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.9 years ago
Interventions
QBSAfe Toolkitother
The QBSAfe toolkit focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety.